Biotech Values

[joe_techi]

Your comment is noted but that doesn't change the fact that Dr. Von Hoff, the world leading authority on treating pancreatic cancer, looked at NVLX technology (cell in a box) and contacted them to pursue his next pancreatic cancer treatment

https://www.tgen.org/research/research-faculty/daniel-von-hoff.aspx#.U8Wn2vldUXs

Now he is working with them, Phase 2b trial in Australia in early 2015 and also a related pre-clinical study with TD2 for pain management associated with abdominal tumors. Dr. Matthias Löhr, a "Von Hoff" European equivalent is also working the Phase 2b.

All bios start off shaky. I bet Celgene was a small, low dollar stock at one point. I know for a fact Opko was a 34 cent stock many years ago. I have owed it since then. OPK is a real example to me of the potential of these type stocks. That has returned 2468% based on today's price. NVLX is worth a look if you are interested in what the experts are working on and the potential of bio ground floor opportunities. Good luck